EUVIMEDEUVIMED entdecken
Open Access

Mechanism of degrader-targeted protein ubiquitinability

Charlotte Crowe iD, Mark A Nakasone iD, Sarah Chandler, Conner Craigon, Gajanan Sathe iD, Michael H Tatham, Nikolai Makukhin iD, Ronald T Hay iD, Alessio Ciulli iD

Science Advances · 11.10.2024 · 10 (41)

DOI: 10.1126/sciadv.ado6492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 11.10.2024. Verfasst von Charlotte Crowe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee DD1 5JJ, UK. Hauptthemen laut MEDLINE: Ubiquitination. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, European Research Council, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small-molecule degraders of disease-driving proteins offer a clinically proven modality with enhanced therapeutic efficacy and potential to tackle previously undrugged targets. Stable and long-lived degrader-mediated ternary complexes drive fast and profound target degradation; however, the mechanisms by which they affect target ubiquitination remain elusive. Here, we show cryo-EM structures of the VHL Cullin 2 RING E3 ligase with the degrader MZ1 directing target protein Brd4 BD2 toward UBE2R1-ubiquitin, and Lys 456 at optimal positioning for nucleophilic attack. In vitro ubiquitination and mass spectrometry illuminate a patch of favorably ubiquitinable lysines on one face of Brd4 BD2 , with cellular degradation and ubiquitinomics confirming the importance of Lys 456 and nearby Lys 368 /Lys 445 , identifying the “ubiquitination zone.” Our results demonstrate the proficiency of MZ1 in positioning the substrate for catalysis, the favorability of Brd4 BD2 for ubiquitination by UBE2R1, and the flexibility of CRL2 for capturing suboptimal lysines. We propose a model for ubiquitinability of degrader-recruited targets, providing a mechanistic blueprint for further rational drug design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UbiquitinationHumansLysineTranscription FactorsUbiquitinProteolysisUbiquitin-Conjugating EnzymesVon Hippel-Lindau Tumor Suppressor ProteinCryoelectron MicroscopyModels, MolecularProtein BindingCell Cycle ProteinsBromodomain Containing Proteins

Substanzen

LysineTranscription FactorsBRD4 protein, humanUbiquitinUbiquitin-Conjugating EnzymesVon Hippel-Lindau Tumor Suppressor ProteinVHL protein, humanCell Cycle ProteinsBromodomain Containing Proteins

Autor:innen und Institutionen

  • Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee DD1 5JJ, UK.
  • Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dow Street, Dundee DD1 5EH, UK.
  • Division of Molecular, Cellular and Developmental Biology, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.

ORCID-Profile: Charlotte Crowe, Mark A Nakasone, Gajanan Sathe, Nikolai Makukhin, Ronald T Hay, Alessio Ciulli

Förderung

  • Wellcome Trust
  • European Research Council
  • Medical Research Council

Zitieren

APA

Crowe, C., Nakasone, M. A., Chandler, S., Craigon, C., Sathe, G., Tatham, M. H., Makukhin, N., Hay, R. T., & Ciulli, A. (2024). Mechanism of degrader-targeted protein ubiquitinability. Science Advances, 10(41). https://doi.org/10.1126/sciadv.ado6492

Vancouver

Crowe C, Nakasone MA, Chandler S, Craigon C, Sathe G, Tatham MH, et al. Mechanism of degrader-targeted protein ubiquitinability. Science Advances. 2024;10(41). doi:10.1126/sciadv.ado6492

BibTeX
@article{Crowe2024,
  author = {Crowe, Charlotte and Nakasone, Mark A and Chandler, Sarah and Craigon, Conner and Sathe, Gajanan and Tatham, Michael H and Makukhin, Nikolai and Hay, Ronald T and Ciulli, Alessio},
  title = {Mechanism of degrader-targeted protein ubiquitinability},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {41},
  doi = {10.1126/sciadv.ado6492}
}
Kostenlos starten →